Selecta Biosciences

About:

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

Website: http://www.selectabio.com

Twitter/X: selectabio

Top Investors: OrbiMed, National Institutes of Health, Polaris Partners, Silicon Valley Bank, I2BF Global Ventures

Description:

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles. It was founded in 2008 and is headquartered in Watertown, Massachusetts.